Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Clinical trial NCT02930902 · COMPLETED

Trial details

NCT number: NCT02930902
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Resectable Pancreatic Carcinoma Stage I Pancreatic Cancer AJCC v6 and v7 Stage IA Pancreatic Cancer AJCC v6 and v7 Stage IB Pancreatic Cancer AJCC v6 and v7 Stage II Pancreatic Cancer AJCC v6 and v7 Stage IIA Pancreatic Cancer AJCC v6 and v7 Stage IIB Pancreatic Cancer AJCC v6 and v7

Start date: 2017-02-20
Primary completion: 2023-01-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.